Advertisement

U.S. markets closed

S&P Futures
3,990.75
+7.75(+0.19%)
Dow Futures
32,518.00
+62.00(+0.19%)
Nasdaq Futures
12,699.50
+11.00(+0.09%)
Russell 2000 Futures
1,769.30
+8.60(+0.49%)
Crude Oil
67.29
-0.35(-0.52%)
Gold
1,983.80
+1.00(+0.05%)

Advertisement

MedMira Inc (47M.BE)

Berlin - Berlin Delayed Price. Currency in EUR

0.0725

-0.0080

(-9.94%)

At close: 08:48PM CET

Advertisement

Loading interactive chart...

ACCESSWIRE
Update on MedMira’s Reveal TP (Syphilis) Clinical Trials in Canada
Today, MedMira Inc. (MedMira) (TSXV:MIR) provides an update on its progress to achieve regulatory approval in Canada for its Reveal® TP (Syphilis) antibody test.
Business Wire
Maternova and MedMira Enter Distribution Agreement to Market Rapid Diagnostics for HIV, Syphilis and Hepatitis
PROVIDENCE, R.I. & HALIFAX, Nova Scotia, February 20, 2023--Maternova gains distribution rights across the U.S. and Latin America for MedMira’s rapid diagnostics for sexually transmitted diseases.
ACCESSWIRE
MedMira Enters into Partnership with Maternova for USA and Latin America
Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the singing of a multinational distribution agreement with Maternova, Inc., Rhode Island, USA.

Advertisement